UnitedHealth Group Incorporated, a leading health care company, has announced the sale of its Brazilian operations to a private investor. The transaction is expected to be finalized in the first half of 2024, pending regulatory and other closing conditions. The company anticipates a charge of approximately $7 billion related to the sale, which will be reflected in its net earnings but excluded from its adjusted earnings. This charge, largely non-cash, is attributed to accumulated foreign currency translation losses. Despite this, UnitedHealth maintains its adjusted earnings outlook for 2024 as previously discussed at its Investor Conference on November 29. The company's forward-looking statements acknowledge potential risks and uncertainties that could affect the actual outcomes, including the ability to meet regulatory and other requirements necessary to complete the sale.

UnitedHealth Group Incorporated, a leading health care company, has announced the sale of its Brazilian operations to a private investor. The transaction is expected to be finalized in the first half of 2024, pending regulatory and other closing conditions. The company anticipates a charge of approximately $7 billion related to the sale, which will be reflected in its net earnings but excluded from its adjusted earnings. This charge, largely non-cash, is attributed to accumulated foreign currency translation losses. Despite this, UnitedHealth maintains its adjusted earnings outlook for 2024 as previously discussed at its Investor Conference on November 29. The company's forward-looking statements acknowledge potential risks and uncertainties that could affect the actual outcomes, including the ability to meet regulatory and other requirements necessary to complete the sale.